Despite the growing popularity of propensity score (PS) methods in epidemiology, relatively
little has been written in the epidemiologic literature about the problem of variable selection …

OBJECTIVE: Large health care utilization databases are frequently used in variety of settings
to study the use and outcomes of therapeutics. Their size allows the study of infrequent …

Background Large health care utilization databases are frequently used to analyze unintended
effects of prescription drugs and biologics. Confounders that require detailed information …

Background Recently, the Food and Drug Administration (FDA) issued an advisory stating
that atypical antipsychotic medications increase mortality among elderly patients. However, …

OBJECTIVE: To develop and validate a single numerical comorbidity score for predicting
short- and long-term mortality, by combining conditions in the Charlson and Elixhauser …

Purpose Real‐world evidence (RWE) includes data from retrospective or prospective
observational studies and observational registries and provides insights beyond those addressed …

Background: Adjusting for large numbers of covariates ascertained from patients’ health
care claims data may improve control of confounding, as these variables may collectively be …

OBJECTIVE: Propensity score (PS) analyses attempt to control for confounding in nonexperimental
studies by adjusting for the likelihood that a given patient is exposed. Such analyses …

Use of propensity scores to identify and control for confounding in observational studies that
relate medications to outcomes has increased substantially in recent years. However, it …

Comorbidity is an important confounder in epidemiologic studies. The authors compared
the predictive performance of comorbidity scores for use in epidemiologic research with …